[HTML][HTML] therapeutic oligonucleotides: An outlook on chemical strategies to improve endosomal trafficking

P Mangla, Q Vicentini, A Biscans - Cells, 2023 - mdpi.com
The potential of oligonucleotide therapeutics is undeniable as more than 15 drugs have
been approved to treat various diseases in the liver, central nervous system (CNS), and …

Disulfide bridging strategies in viral and nonviral platforms for nucleic acid delivery

K Dutta, R Das, J Medeiros, S Thayumanavan - Biochemistry, 2021 - ACS Publications
Self-assembled nanostructures that are sensitive to environmental stimuli are promising
nanomaterials for drug delivery. In this class, disulfide-containing redox-sensitive strategies …

Sulfonium-driven neoantigen-released DNA nanodevice as a precise vaccine for tumor immunotherapy and prevention

Y Zhang, H Xu, L Jiang, Z Liu, C Lian, X Ding, C Wan… - ACS …, 2022 - ACS Publications
Peptide-based neoantigen vaccines hold tremendous potential for personalized tumor
immunotherapy. However, effective delivery and controllable release of antigen peptides …

Toward Clinical Transfer of Tumor‐Targeted Ultrasmall Inorganic Nanoparticles

L Carmès, M Banerjee, P Coliat, S Harlepp… - Advanced …, 2023 - Wiley Online Library
Ultrasmall nanoparticles (USNs)(nanoparticles with hydrodynamic diameter< 10 nm) are
being widely developed pre‐clinically and started to emerge in clinical trials over the last …

Disulfide bridge as a linker in nucleic acids' bioconjugation. Part II: A summary of practical applications

AR Stasińska, P Putaj, MK Chmielewski - Bioorganic Chemistry, 2020 - Elsevier
Disulfide conjugation invariably remains a key tool in research on nucleic acids. This
versatile and cost-effective method plays a crucial role in structural studies of DNA and RNA …

Cysteine‐Cysteine Cross‐Conjugation of both Peptides and Proteins with a Bifunctional Hypervalent Iodine‐Electrophilic Reagent

I Koutsopetras, AK Mishra, R Benazza… - … A European Journal, 2023 - Wiley Online Library
Peptide and protein bioconjugation sees ever‐growing applications in the pharmaceutical
sector. Novel strategies and reagents that can address the chemo‐and regioselectivity …

Revolutionizing DNA: advanced modification techniques for next-gen nanotechnology

P Panda, R Mohapatra - Nucleosides, Nucleotides & Nucleic Acids, 2024 - Taylor & Francis
The comprehensive advancement in DNA modification and coupling is driving DNA
nanotechnology to new heights, paving the way for groundbreaking innovations in …

Low bias charge transport in DNA

M Wiesner, J Barciszewski, A Belter, A Sierakowski… - Scientific Reports, 2024 - nature.com
The low-bias current–voltage technique was utilized to study charge transport in single-
stranded DNA (ssDNA), assessing the method's effectiveness for future studies aimed at …

[HTML][HTML] Conjugation of doxorubicin to siRNA through disulfide-based self-immolative linkers

F Gauthier, JR Bertrand, JJ Vasseur, C Dupouy… - Molecules, 2020 - mdpi.com
Co-delivery systems of siRNA and chemotherapeutic drugs have been developed as an
attractive strategy to optimize the efficacy of chemotherapy towards cancer cells with …

Synthesis of a convertible linker containing a disulfide group for oligonucleotide functionalization

A Pontarelli, JT Liu, H Movasat, S Ménard, JK Oh… - Organic …, 2022 - ACS Publications
The synthesis and incorporation of a tosylated phosphoramidite linker containing a disulfide
bond is described. Incorporation of the linker into short DNA and RNA oligomers proceeded …